One of my favourite stocks in the health sector $SLHG recently released their Q2 financial results and showed some great results.
Highlights
- Revenue increased 184% to $10.5 million, driven by acquisitions and organic growth (up 103% from $5.2 million for the first quarter of 2021)
- Organic growth from existing Primary Care clinics of approximately 13% during the quarter
- Executed clinical trial contracts expected to generate revenue with strong margin potential
- Cash balance of $11.8 million as of June 30, 2021
- Etc.
CEO of $SLHG commented, “We are excited that we achieved our largest revenue quarter in the history of the Company . . . We’ve identified two key growth areas that will remain a focus for the last half of the year and onwards: the growth through strategic acquisitions and the participation of value-based care.”
Lots to love from these results, excited to see what $SLHG does the rest of the year.
https://skylighthealthgroup.com/2021/08/16/skylight-health-group-reports-record-second-quarter-2021-financial-results/